1620 Investment Advisors’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$182K Sell
17,200
-2,544
-13% -$27.8K 0.11% 190
2026
Q1
$229K Buy
19,744
+310
+2% +$3.87K 0.15% 142
2025
Q4
$222K Sell
19,434
-4,034
-17% -$47.4K 0.15% 149
2025
Q3
$298K Buy
23,468
+1,554
+7% +$22.5K 0.2% 127
2025
Q2
$348K Buy
+21,914
New +$328K 0.25% 113

Other funds holding XRAY

1620 Investment Advisors's XRAY Position: Q2 2026 in Review

1620 Investment Advisors reduced its Dentsply Sirona (XRAY) stake by 13% in Q2 2026, selling an estimated $27.8K and leaving 17,200 shares worth $182K. The position accounts for 0.11% of the portfolio, ranked #190.

1620 Investment Advisors first reported a position in XRAY in Q2 2025 and has held it in 5 quarters since. The position peaked at $348K in Q2 2025. 40 funds tracked by Wall St. Rank hold XRAY as of Q2 2026.

  • 1620 Investment Advisors held 17,200 shares of Dentsply Sirona worth $182K as of Q2 2026.
  • 1620 Investment Advisors sold 2,544 Dentsply Sirona shares in Q2 2026, an estimated $27.8K.
  • Dentsply Sirona made up 0.11% of 1620 Investment Advisors's portfolio in Q2 2026, its #190 holding.
  • 1620 Investment Advisors first reported a position in Dentsply Sirona in Q2 2025 and has held it in 5 quarters since.
  • 1620 Investment Advisors's Dentsply Sirona position peaked at $348K in Q2 2025.
  • 40 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2026.

Based on 1620 Investment Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.